/biz/ - Business & Finance

I'm pleading with you when I say buy TMDX, or at least DCA into it. The upcoming earnings should be good because they sold a decent amount and hospitals were approved to charge off part of the cost of these $250k machines on the taxpayer courtesy of Medicare. The next earnings should be even better thanks to the January sales spurred by the first ever DCD transplant facilitated by their machines. I'll put it this way, about 50 or so transplant centers do 95% of heart and lung transplants. Only 4 were enrolled in OCS studies in Q2 2019, this is all info you can find via Google btw. They were able to sell about 18 machines and the accompanying perfusion sets to just these 4 centers and pull in about $5.5 million in revenue.

These machines are now FDA approved for routine use, multiple centers have bought them and integrated them into their routine operations, an additional heart study and a liver study is ongoing still. These centers are eager to increase their transplant rates and thus increase their revenue, they're getting these expensive machines at a discount courtesy of Uncle Sam (and us), more centers than ever are involved in operations using these machines. Most of this happened at the end of 2019 or early this year.

It won't 2x overnight but this shit will absolutely be in the low 100s this time next year if this trend keeps up and the company isn't scooped up by UTHR, who has been on a roll lately of acquiring anybody and everybody transplant related. This isn't financial advice, I only have 500 shares in this company most of I got from buying every >$1 dip. Hopefully it makes sense, this is my last day off before another week on call so I'm day drunk. Good luck in the market today friends. Also, fuck tripfags.